Clinical Trial: A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19

U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT04822701) titled 'A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19' on March 29.

Brief Summary: This study is open to adults with mild to moderate symptoms of COVID-19 (coronavirus disease). The purpose of this study is to find out whether a medicine called BI 767551 helps people with COVID-19. BI 767551 is an antibody against the coronavirus.

The study has 2 parts.

Part 1 wants to find out the best dose of BI 767551 given as infusion into a vein. It also tests how BI 767551 is taken up by the body when taken via an inhaler. Participants are put into 4 groups by chance. Participants get BI 767551 or placebo once.

* 1...